uniQure Researchers Swap Out Lead Drug for a Better Prospect Post author:Sam Post published:October 18, 2017 Post category:BioPharma The company plans to expeditiously advance AMT-061 instead of AMT-060. Source: BioSpace You Might Also Like Debt-Ridden Teva Considers Cutting Up to 10,000 Jobs December 10, 2017 <b>Luye Life Sciences</b> Expands Global Reach As New Boston R&D Center Opens July 16, 2017 On a Roll, Seattle Genetics Plans to Hire 200 in 2017 January 23, 2017
